Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Informationsteknik |
| Industri | Programvara |
Aiforia Technologies Plc, Company release, October 29, 2024 09:00 a.m. EET
Aiforia Technologies Plc’s financial reporting and Annual General Meeting in financial year 2025
The calendar for Aiforia Technologies Plc’s financial reporting concerning the financial year 2025 is as follows:
- March 7, 2025: Financial Statements Bulletin for financial year 2024
- March 14, 2025: The Financial Statements and the Board of Directors’ Report for financial year 2024
- August 28, 2025: Half-Year Financial Report for 1 January–30 June 2025
Aiforia Technologies’s Annual General Meeting will be held on April 4, 2025. The Board of Directors will convene the meeting with a separate company release at a later date.
More information on the events of the financial year will be available on the company’s investor pages at https://investors.aiforia.com/investor-calendar.
Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358405009878
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more at www.aiforia.com